Faron Pharmaceuticals Oy (FRA:4FR) successfully raised EUR35.5 million through a combined transaction, improving their cash position significantly. The company reported a reduction in losses from ...
14d
Faron Pharmaceuticals Oy (FRA:4FR) reports improved cash position and reduced losses, while navigating regulatory and commercialization hurdles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback